Presented at the 66th session of the WHO Regional Committee for Europe by: Dr Oleg Chestnov, Assistant Director-General, WHO Dr Jill Farrington, Acting Head, NCD Project Office, Moscow Dr Gauden Galea, Director, Noncommunicable Diseases and Promoting Health through the Life-course, WHO/Europe

1. Action plan for the prevention and
control of noncommunicable diseases
(NCDs) in the WHO European Region
Dr Oleg Chestnov, Assistant Director-General
Dr Jill Farrington, Acting Head, NCD Project Office, Moscow
Dr Gauden Galea, Director
Noncommunicable Diseases and
Promoting Health through the Life-course

2. Getting to 2018
2011
Political
Declaration
2014
Outcome
Document
2015
SDGs
2015
Addis Ababa
Action
Agenda
2011
Moscow
Declaration
2018
3rd High-
level
Meeting
2

3. Getting to 2017
United Nations General Assembly
 Progress report on how countries have implemented the four time-bound commitments (national
targets, national NCD plan, risk factor reduction, health systems response)
United Nations Economic and Social Council
 Progress report on the expanded mandate of the United Nations Task Force on NCDs
 Self-reporting of countries on health in national SDG responses to the High-level Political Forum
World Health Assembly
 Updated Appendix 3 (= best buys + good buys)
 Approach to measure the contribution from non-State actors to NCD targets
Organisation for Economic Co-operation and Development’s
Development Assistant Committee
 Creditor Reporting System codes to track official development assistance for NCDs
3

4. Source: WHO. European Health for All database, 2015
Regional trends in overall premature NCD mortality are promising
4
0
100
200
300
400
500
600
700
800
900
1000
2000 2002 2004 2006 2008 2010 2012 2014 2016 2018 2020 2022 2024
SDR,ages30–69years,mainNCD,per100000
Age-standardized premature NCD death rates 30─69 and projections to 2025
European Region EU members before May 2004
EU members since May 2004 NIS

5. Decline in coronary heart disease mortality: contribution of
prevention and treatment
46%
42%
52%
44%
43%
47%
43%
40%
43%
40%
40%
46%
23%
24%
23%
25%
37%
43%
50%
55%
48%
47%
44%
52%
34%
48%
48%
50%
50%
54%
39%
51%
60%
50%
72%
76%
72%
70%
54%
52%
41%
40%
51%
42%
10%
6%
14%
8%
9%
3%
7%
7%
18%
9%
4%
5%
5%
5%
8%
5%
9%
5%
1%
11%
0% 10% 20% 30% 40% 50% 60% 70% 80% 90% 100%
The Netherlands 1978-1985 (Bots & Grobbee)
England & Wales 1981-2000 (IMPACT)
England 2000-2007 (IMPACT)
Ireland 1985-2000 (IMPACT)
Canada 1994-2005 (IMPACT)
USA 1980-2000 (IMPACT)
USA 1980-1990 (Hunink et al)
USA 1968-1976 (Goldman et al)
Scotland 2000-2010 (IMPACT)
Scotland 1975-94 (IMPACT)
New Zealand 1974-1981 (Jackson et al)
New Zealand 1982-1993 (IMPACT)
Finland 1982-1997 (IMPACT)
Finland 1972-1992 (Vartiainen et al)
Sweden 1986-2002 (IMPACT)
Iceland 1981-2006 (IMPACT)
Poland 1991-2005 (IMPACT)
Czech Republic 1985-2007 (IMPACT)
Slovakia 1993-2008 (IMPACT)
Italy 1980-2000 (IMPACT)
Spain 1988-2005 (IMPACT)
Turkey 1995-2008 (IMPACT)
Treatments
Risk factors
Unknown
5

6. Developments since last European NCD Action Plan
• Regional mandate for all 4
risk factors
• Geographically dispersed
office in Moscow and
NCD project
• Commitments have leapt
forward – surveys, action plans
• Health systems strengthening
for better NCD outcomes
6

7. PRIORITY
ACTION AREAS
Governance
Surveillance,
monitoring and
evaluation, research
Prevention and
health promotion
Health systems
Population-level
Fiscal and marketing
policies
Salt reduction
Clean air
Active living and
mobility
Product reformulation
and improvement
Individual-level
Cardio-metabolic risk
assessment and
management
Early detection and
effective treatment
Vaccination and
communicable
disease control
SUPPORTING
INTERVENTIONS
Oral health and
musculoskeletal
health
Mental health
Health in specific
settings
Overview of European NCD Action Plan 2016–2025
PRIORITY INTERVENTIONS
7

8. Contributions of existing WHO strategies and action plans
to achieving the new European NCD Action Plan
8

9. THANK YOU
Thank you
9